Nexus NeuroTech Ventures has a deep commitment to supporting solutions that hold the greatest promise to help people with neurological and psychiatric disorders, such as Parkinson’s disease, bipolar disorder, and autism.
Investment Stage: Series B
Portfolio 1
| Date | Name | Website | Total Raised | Location |
| 16.11.2025 | Beacon Bio... | beacon.bio | $113M | United Sta... |
Mentions in press and media 14
| Date | Title | Description |
| 19.12.2025 | NeuraWorx Medical Technology Closes Seed Funding Round | Neuraworx Medical Technology, Inc., an Excelsior, Minn.-based neurotechnology company developing first-in-class bioelectronic solutions for brain health originally developed at the University of Wisconsin-Madison, closed its Seed funding ro... |
| 18.11.2025 | Beacon Biosignals Secures $86M to Revolutionize Brain Disorder Treatment | Beacon Biosignals landed $86M in Series B funding. They plan to use it to improve diagnostics and treatment using AI. Their neurotechnology targets brain disorders. The funding helps them expand and accelerate discovery. This positions them... |
| 16.11.2025 | Beacon Biosignals: $86 Million Series B Raised To Advance AI-Driven Neurodiagnostics And Precision Neuroscience | Beacon Biosignals has raised an oversubscribed $86 million Series B to accelerate the clinical adoption of AI-powered biomarkers for neurological and psychiatric disease, expand its precision medicine data platform, and scale its neurodiagn... |
| 13.11.2025 | Beacon Biosignals Raises $86M in Series B Funding | Beacon Biosignals, a Boston, MA-based neurotechnology company powering AI-driven diagnostics and precision medicines for the brain, raised $86m in Series B funding. Backers included Innoviva, Google Ventures (GV), Nexus NeuroTech Ventures, ... |
| 12.11.2025 | Modulight Biotherapeutics Raises $12M in Seed Funding | Modulight Biotherapeutics, a Boston, MA-based developer of novel optogenetic platform for the treatment of neurological disorders, raised $12.2M in Seed funding. The round was led by Jibe Ventures and LocalGlobe, with participation from Nex... |
| 12.11.2025 | Modulight Biotherapeutics: $12.2 Million Seed Round Raised To Pioneer Light-Based Therapies For Neurological Disorders | Modulight Biotherapeutics announced the closing of its $12.2 million Seed funding round to accelerate the development of its novel optogenetic therapy platform targeting neurological disorders. The round was led by Jibe Ventures and LocalGl... |
| 22.10.2025 | Ampa Raises $8.5M in Pre-A Funding | A clinician administering treatment with the Ampa One system – a portable, cameraguided TMS device designed to make advanced brain stimulation more accessible and easy to deliver. Ampa, a Palo Alto, CA-based neurotechnology company, raised ... |
| 28.01.2025 | Nobi Raises €35M in Series B Financing | Nobi, an Antwerpen, Belgium-based AgeTech company, raised €35M in Series B funding. The round was co-led by Angelini Ventures and Nexus NeuroTech Ventures, with participation from 15th Rock, and existing investors EQT Health Economics and E... |
| 10.12.2024 | Cala Health's $50 Million Surge: A New Dawn for Tremor Therapy | Cala Health is making waves. The California-based company has just secured $50 million in a growth funding round. This isn't just a financial boost; it's a lifeline for those grappling with essential tremor. Cala Health specializes in bioel... |
| 09.12.2024 | Cala Health Closes $50M Financing | Cala Health, a San Mateo, CA-based non-invasive bioelectronic medicine company, raised $50M in funding. The round was led by Vertex Growth Fund and Nexus NeuroTech Ventures. Existing investors participated in the round, including Action Pot... |
Show more